Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease
Pharma
Viatris may not have infringed on Symbicort's patents
Viatris and Kindeva have tentative approval for the first generic of AZ's Symbicort, but a trio of patents stands in the way of the copycat's launch.
Fraiser Kansteiner
Dec 13, 2021 3:50pm
Carlyle is buying British inhaled meds CDMO Vectura for $1.4B
May 26, 2021 8:57am
GSK recalling nearly 600,000 Ventolin inhalers in U.S.
Apr 4, 2017 9:29am
Novartis hopes Seretide-topping data can push docs toward Ultibro
May 16, 2016 9:58am